USPTO serial 79284818
Reviewed by CopyMark Law Group
This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Plus Government fees of $1,950
OXFORD NANOPORE TECHNOLOGIES LIMITED
GB
Other trademarks owned by OXFORD NANOPORE TECHNOLOGIES LIMITED
OXFORD NANOPORE TECHNOLOGIES LIMITED
GB
Other trademarks owned by OXFORD NANOPORE TECHNOLOGIES LIMITED
OXFORD NANOPORE TECHNOLOGIES LIMITED
GB
Other trademarks owned by OXFORD NANOPORE TECHNOLOGIES LIMITED
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Christina M. Licursi
Christina M. Licursi Wolf Greenfield & Sacks, P.C.600 Atlantic AvenueBoston, MA 02210UNITED STATES| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Chemical diagnostic reagents for scientific use; reagents for use in automated test systems not for medical purposes; reagents for analytical tests not for medical purposes; reagents for industrial use, namely, for laboratory use and scientific testing and research use in the fields of molecular biology, biotechnology, microbiology, bacteriology and genomics; reagents for use in science; reagents for laboratory use; reagents for use in molecular biology, biotechnology, microbiology, and bacteriology; reagents for nucleic acid amplification; reagents for use in forensic analysis; reagents for use in environmental testing and environmental analysis; reagents for testing water and other liquids; reagents for testing aqueous solutions; deoxyribonucleic acid, single stranded and double stranded deoxyribonucleic acid for laboratory use and scientific testing and research use; ribonucleic acid for laboratory use and scientific testing and research use; peptide nucleic acids for laboratory use and scientific testing and research use in the fields of molecular biology, biotechnology, microbiology, bacteriology and genomics; locked nucleic acids for laboratory use and scientific testing and research use in the fields of molecular biology, biotechnology, microbiology, bacteriology and genomics; nucleic acids, oligonucleotides, oligosaccharides, proteins and peptides all for laboratory use and scientific testing and research use in the fields of molecular biology, biotechnology, microbiology, bacteriology and genomics; chemicals, enzymes and reagents for use in genome, DNA, RNA and nucleic acid synthesis; endonucleases, polymerases, ligases, glycosylases for use in analytical tests for scientific and scientific research purposes; nucleotides, pyrimidines, purines; amino acids for use in analytical tests for scientific and scientific research purposes; saccharides for use in analytical tests for scientific and scientific research purposes; reagents for biological processing; reagents for use in nucleic acid characterisation and nucleic acid sequencing; reagents for protein identification and analysis; chemicals for use in tests to detect diseases in plant life other than pesticides; reagents for formation of amphipathic membranes; chemicals, namely, buffer solutions for scientific and research use; isopropanol; ethanol; phenol for scientific and research use; surfactants for scientific and research use; silicone oils for scientific and research use; silicone fluids; enzymes for scientific and research use; lytic enzymes including lysozyme, lyticase and cellulose for scientific and research use; proteases; nucleases, including RNase, DNase and restriction enzymes for laboratory use and scientific testing and research use in the fields of molecular biology, biotechnology, microbiology, bacteriology and genomics; chaotropes, including guanidine-HCl and guanidinium thiocyanate for laboratory use and scientific testing and research use in the fields of molecular biology, biotechnology, microbiology, bacteriology and genomics; detergents for industrial and scientific use; proteins for use in analytical tests for scientific and research use; all the aforesaid other than for medical or veterinary purposes; magnetic and non-magnetic microspheres made from synthetic materials including rubber, plastics or silicone, namely, beads for use in medical and scientific research | ACTIVE | — |
| 005 | Reagents for use in automated test systems for medical and veterinary use; reagents for use in blood grouping, molecular biology, bacteriological, biotechnology and microbiological analysis, including reagents for formation of amphipathic membranes, buffer solutions, non-aqueous solvents, surfactants, all for medical and veterinary use; reagents for medical and veterinary diagnosis; reagents for laboratory tests for medical or veterinary purposes; nucleic acid amplification reagents for veterinary and medical purposes; reagents for medical or veterinary use, namely, reagents for immunoassay analysers; reagents for medical or veterinary use, namely, reagents for testing aqueous solutions; reagents for medical or veterinary use, namely, for testing for susceptibility to allergies; reagents for medical or veterinary use, namely, for use in biological processing; reagents for medical or veterinary use, namely, reagents for use in nucleic acid characterisation and nucleic acid sequencing; reagents for protein identification and analysis for medical or veterinary use; reagents for medical or veterinary use, namely, reagents for formation of amphipathic membranes; chemicals, namely, buffer solutions for medical or veterinary use; surfactants for use in medical and veterinary diagnostic tests; enzymes for use in tests for medical and veterinary purposes; protein arrays for use in tests for medical or veterinary purposes; magnetic and non-magnetic microspheres made from synthetic materials including rubber, plastics or silicone, namely, beads for medical or veterinary purposes | ACTIVE | — |
| 009 | Downloadable computer software for running an e-commerce platform; downloadable software for use in analysing, transmitting and receiving data via a global communications network; downloadable software for developing, running and communicating with software on data processing apparatus, scientific apparatus, medical and veterinary apparatus, computers, mobile phones, tablet computers and handheld mobile digital electronic devices; downloadable computer operating software; downloadable computer operating system software; downloadable operating software for data processing apparatus, scientific apparatus, medical and veterinary apparatus, computers, mobile phones, tablet computers and handheld mobile digital electronic devices; laboratory equipment, namely, micro-array chips; electronic sensing apparatus for analysing chemical, biochemical, biological, bacteriological and microbiological test samples for scientific testing purposes; apparatus and instruments, namely, optical or electrochemical readers for the analysis of biological, bacteriological, chemical, biochemical, DNA, RNA, protein, polynucleic acid and molecular test samples and the measurement of ions; portable apparatus and instruments, namely, optical or electrochemical readers for the analysis of biological, bacteriological, chemical, biochemical, DNA, RNA, protein, polynucleic acid and molecular test samples for and the measurement of ions; portable optical or electrochemical readers for the analysis of biological, bacteriological, chemical, biochemical, DNA, RNA, protein, polynucleic acid and molecular test samples for medical diagnostic purposes; scientific instruments, namely, sequencing devices for use in DNA, RNA, protein and polynucleic acid sequencing; downloadable computer software and optical and electrochemical readers for the scientific analysis of polynucleic acid sequences; downloadable computer software and optical and electrochemical readers for the analysis of nucleic and polynucleic acids; scientific apparatus and instruments for the analysis of proteins; apparatus and instruments for the analysis of genetic information, genomic information and proteomic information, namely, automated instruments for detecting the presence, properties and identity of analytes, comprising cartridges, microarrays, silicon chip based arrays, ASICS (application specific integrated circuits), and networked computer hardware and downloadable software for performing and controlling the analysis, and for processing, displaying and storing the information obtained from the analysis; downloadable computer programs, computer hardware and data processing apparatus, all for the analysis and recordal of scientific data; scientific apparatus and instruments for synthesising chemical compounds, small molecules, genomes, DNA, RNA or other nucleic acids, oligosaccharides, proteins and peptides for scientific research and scientific testing purposes; data processing apparatus, devices and instruments; scientific apparatus, devices and instruments for identifying, measuring, analysing, sequencing or synthesising small molecules, genomes, DNA, RNA or other nucleic acids, oligosaccharides, proteins and peptides for scientific research and scientific testing purposes; portable computer hardware and data processing apparatus, all for the analysis and recordal of scientific data; computer peripheral devices; electronic display interfaces for the display of information obtained from scientific equipment; silicon chips; DNA chips; analyte detector chips for scientific or research use; biosensor chips for scientific or research use; cartridges being laboratory and scientific apparatus for holding biological, bacteriological, chemical, biochemical, DNA, RNA, protein, polynucleic acid and molecular test samples; batteries; rechargeable batteries; chargers for batteries; power packs in the nature of batteries; computer docking stations; apparatus for connecting and charging portable digital electronic devices; Nanopore sensing devices for laboratory use and scientific testing and research use; parts and fittings for all the aforesaid goods | ACTIVE | — |
| 010 | Medical apparatus and instruments for biological, chemical, biochemical, DNA, RNA, protein and molecular analysis; veterinary apparatus and instruments for biological, chemical, biochemical, DNA, RNA, protein and molecular analysis; portable medical and veterinary apparatus for diagnosing genetic disorders for medical purposes; blood testing apparatus; genetic disorder diagnostic apparatus for medical or veterinary purposes; portable genetic disorder diagnostic apparatus for medical or veterinary purposes; immunochemical testing apparatus for medical or veterinary purposes; portable immunochemical testing apparatus for medical or veterinary purposes; cartridges for test samples, for medical purposes; reaction units containing chemical reagents, for medical purposes; nanopore sensing devices for medical or veterinary purposes; parts and fittings for all the aforesaid goods | ACTIVE | — |
| 035 | Analysis and evaluation of marketing, business and commercial data; provision of reports relating to the aforesaid; business information services; analysis and evaluation of business information; retail store services featuring software; retail store services featuring computer operating software; retail store services featuring data analysis products and services and data streaming products and services; retail store services featuring electronic sensing and measuring equipment, apparatus and instruments; retail store services featuring sequencing equipment, apparatus and instruments; retail store services featuring data processing equipment, apparatus and instruments; retail store services featuring scientific equipment, apparatus and instruments; retail store services featuring surgical, medical and veterinary equipment, apparatus and instruments; retail store services featuring reagents, buffer solutions, solvents, surfactants, oils and other media for scientific, medical or veterinary purposes; retail store services featuring chemicals and enzymes; retail store services featuring chemicals and enzymes for scientific, medical or veterinary purposes; retail store featuring deoxyribonucleic acid, single stranded and double stranded deoxyribonucleic acid, ribonucleic acid, peptide nucleic acids, locked nucleic acids, nucleic acids, oligonucleotides, oligosaccharides, proteins and peptides; retail store services featuring goods for laboratory use; information, advisory and consultancy services relating to the aforesaid | ACTIVE | — |
| 042 | Scientific and technological services and research and design relating thereto, namely, consultation, research and design services relating to automated systems and instruments for direct electrical detection and analysis of molecules for use in the field of genomics, protein analysis, molecular analysis, life sciences, healthcare, security and defence; industrial analysis and research services in the fields of genomics, protein analysis, molecular analysis, life sciences, healthcare, security and defence; scientific research for chemical, biochemical, biological, bacteriological, medical or veterinary purposes; biological, chemical, biochemical, bacteriological, DNA, RNA, protein, polynucleic acid and molecular analysis services, namely, biological, chemical, biochemical, bacteriological DNA, RNA, protein, polynucleic acid and molecular analysis for scientific or research purposes; scientific and technological services, namely, synthesising chemical compounds, small molecules, genomes, DNA, RNA or other nucleic acids, oligosaccharides, proteins and peptides; scientific research for medical or veterinary purposes; DNA and RNA and polynucleic acid sequencing services for scientific research purposes; protein sequencing services for scientific research purposes; design and development of instruments and apparatus for biological, chemical, biochemical, DNA, RNA, protein and molecular analysis; DNA and polynucleic acid testing services, namely, the analysis of DNA and polynucleic acids for scientific and scientific research purposes; genome sequencing services for scientific testing and scientific research purposes; analysis and evaluation of data, not for medical treatment or diagnostic purposes, namely, scientific and medical data; computerised analysis of technical data namely, the results of scientific tests and experiments; overseeing, monitoring and managing scientific and medical experiments and tests for scientific research purposes; overseeing, monitoring and managing the analysis and evaluation of scientific and medical data for scientific research purposes; design of scientific experiments; analysis of data generated by scientific and medical experiments and tests for scientific research purposes; scientific and technological services, namely, biological, bacteriological, chemical, biochemical, DNA, RNA, protein, polynucleic acid and molecular analysis and evaluation services; scientific and technological services, namely DNA and RNA and polynucleic acid and protein sequencing, analysis and evaluation services; scientific and technological services, namely, genome sequencing services and the analysis and evaluation of data resulting therefrom; provision of reports relating to scientific and medical experiments, the results of scientific and medical experiments and tests, the analysis and evaluation of scientific and medical data, and data generated by scientific and medical experiments and tests none being for medical treatment or diagnostic purposes; scientific and medical research and development services in the fields of scientific, technological and medical research; technical data analysis and evaluation services in the fields of scientific, medical technology and medical research; electronic data storage services; application service provider (ASP) services featuring computer software applications installed or downloaded onto data processing apparatus, scientific apparatus, medical and veterinary apparatus, computers, mobile phones, tablet computers and handheld mobile digital electronic devices for the analysis of scientific data; information, advisory and consultancy services relating to the aforesaid | ACTIVE | — |
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
| Date | Code | Event | What it means |
|---|---|---|---|
| Jun 15, 2026 | REM3 | COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED | — |
| Nov 15, 2021 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Nov 6, 2021 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Sep 30, 2021 | XXSS | GENERIC MADRID TRANSACTION SENT TO IB | — |
| Sep 30, 2021 | XXCR | GENERIC MADRID TRANSACTION CREATED | — |
| Sep 15, 2021 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Jun 15, 2021 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Mar 30, 2021 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Mar 30, 2021 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Mar 28, 2021 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Mar 10, 2021 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Mar 10, 2021 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Mar 10, 2021 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Feb 25, 2021 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Feb 9, 2021 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Feb 8, 2021 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Feb 8, 2021 | ERFR | TEAS REQUEST FOR RECONSIDERATION RECEIVED | — |
| Oct 13, 2020 | GNFN | NOTIFICATION OF FINAL REFUSAL EMAILED | — |
| Oct 13, 2020 | GNFR | FINAL REFUSAL E-MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Oct 13, 2020 | CNFR | FINAL REFUSAL WRITTEN | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Sep 22, 2020 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Sep 22, 2020 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Sep 22, 2020 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Sep 21, 2020 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| Sep 21, 2020 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Sep 21, 2020 | ECDR | TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS | — |
| Sep 21, 2020 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Sep 21, 2020 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Sep 21, 2020 | COAR | TEAS CHANGE OF OWNER ADDRESS RECEIVED | — |
| Jul 23, 2020 | ATRV | ATTORNEY REVIEW COMPLETED | — |
| Jul 10, 2020 | RFNT | REFUSAL PROCESSED BY IB | — |
| Jul 9, 2020 | CREV | CORRECTION FROM IB ENTERED - ATTORNEY REVIEW REQUIRED | — |
| Jul 3, 2020 | CRCV | CORRECTION TRANSACTION RECEIVED FROM IB | — |
| Jun 18, 2020 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Jun 18, 2020 | RFRR | REFUSAL PROCESSED BY MPU | — |
| May 17, 2020 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| May 16, 2020 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| May 15, 2020 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| May 11, 2020 | DOCK | ASSIGNED TO EXAMINER | — |
| May 11, 2020 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| May 7, 2020 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |